Education
About Us
Working with TipRanks
Follow Us
Emcure Pharmaceuticals Limited (IN:EMCURE)
:EMCURE
Summary of all the Indicators
Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Emcure Pharmaceuticals Limited’s (EMCURE) Moving Averages Convergence Divergence (MACD) indicator is -8.46, suggesting Emcure Pharmaceuticals Limited is a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 20-Day exponential moving average is 1479.36, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Sell.
Emcure Pharmaceuticals Limited’s (EMCURE) 50-Day exponential moving average is 1467.69, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Sell.
Emcure Pharmaceuticals Limited (EMCURE) Pivot Points
Classic
1,359.87
1,391.38
1,413.62
1,445.13
1,467.37
1,498.88
1,521.12
Fibonacci
1,391.38
1,411.92
1,424.60
1,445.13
1,465.67
1,478.35
1,498.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Emcure Pharmaceuticals Limited (EMCURE) Moving Averages
MA5
1,455.57Sell
1,453.69Sell
MA10
1,478.22Sell
1,467.95Sell
MA20
1,481.63Sell
1,479.36Sell
MA50
1,471.46Sell
1,467.69Sell
MA100
1,421.00Buy
1,428.82Buy
MA200
1,374.54Buy
1,343.62Buy
Emcure Pharmaceuticals Limited’s (EMCURE) 10-Day exponential moving average is 1467.95, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Sell.
Emcure Pharmaceuticals Limited’s (EMCURE) 100-Day exponential moving average is 1428.82, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹1,345.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,345.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 50-day simple moving average is 1471.46, creating a Sell signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,345.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 100-day simple moving average is 1421.00, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹1,345.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 200-day simple moving average is 1374.54, creating a Buy signal.
Emcure Pharmaceuticals Limited (EMCURE) Technical Indicators
RSI (14)
42.68
Neutral
STOCH (9,6)
12.22
Buy
STOCHRSI (14)
16.76
Buy
MACD (12,26)
-8.46
Buy
ADX (14)
17.49
Buy
Williams %R
-87.03
Buy
CCI (14)
-125.51
Buy
ATR (14)
49.66
-
Ultimate Oscillator
45.41
Neutral
ROC
-2.21
Sell
Emcure Pharmaceuticals Limited’s (EMCURE) Relative Strength Index (RSI) is 42.68, creating a Neutral signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Trend Strength Indicator (ADX) is 17.49, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Commodity Channel Index (CCI) is -125.51, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) Price Rate of Change (ROC) is -2.21, creating a Sell signal.
FAQ
Is EMCURE a Buy, Hold, or Sell?
Based on EMCURE’s technical indicators, EMCURE is a Hold.
What is EMCURE’s RSI (14)?
EMCURE’s RSI (14) is 42.68, which suggests EMCURE is a Neutral.
What is EMCURE’s MACD?
EMCURE’s MACD is -8.46, which suggests EMCURE is a Buy.
What is EMCURE’s 5-day moving average?
EMCURE’s 5-day moving average is 1455.57, which suggests EMCURE is a Sell.
What is EMCURE’s 20-day moving average?
EMCURE 20-day moving average is 1481.63, which suggests EMCURE is a Sell.
What is EMCURE’s 50-day moving average?
EMCURE’s 50-day moving average is 1471.46, which suggests EMCURE is a Sell.
What is EMCURE’s 200-day moving average?
EMCURE’s 200-day moving average is 1374.54, which suggests EMCURE is a Buy.
What is EMCURE’s Williams % R (14)?
EMCURE’s Williams % R (14) is -87.03, which suggests EMCURE is a Buy.
What is EMCURE’s CCI (14)?
EMCURE’s CCI (14) is -125.51, which suggests EMCURE is a Buy.
What is the share price of Emcure Pharmaceuticals Limited?